SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chalu2 who wrote (295)1/17/2000 8:10:00 AM
From: Steve Johnston  Read Replies (1) of 298
 
AIMM is currently only a shell company. All clinicals in oral tolerance therapy have failed and their research program is essentially dead. What is driving the price is the ongoing rumour that someone will pump money into their products to market them as nutraceutical OTC's. Bishop is on record as denying this, following the stock run-up to $4 a few months ago. Aside from this, there is nothing else noteworthy to post. Regards.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News